Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP926871.RAUUgiraPADDZZ_gzj889CqulIID-VUq6UAwjVezB8RS8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926871.RAUUgiraPADDZZ_gzj889CqulIID-VUq6UAwjVezB8RS8130_assertion type Assertion NP926871.RAUUgiraPADDZZ_gzj889CqulIID-VUq6UAwjVezB8RS8130_head.
- NP926871.RAUUgiraPADDZZ_gzj889CqulIID-VUq6UAwjVezB8RS8130_assertion description "[Anticholinesterase therapy is effective in most of them, but is contraindicated in endplate (EP) acetylcholinesterase (AChE) deficiency, the slow-channel syndrome, Dok-7 myasthenia, and ?(2) -laminin deficiency, and is not useful in CMS due to defects in muscle-specific kinase (MuSK), agrin, and plectin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926871.RAUUgiraPADDZZ_gzj889CqulIID-VUq6UAwjVezB8RS8130_provenance.
- NP926871.RAUUgiraPADDZZ_gzj889CqulIID-VUq6UAwjVezB8RS8130_assertion evidence source_evidence_literature NP926871.RAUUgiraPADDZZ_gzj889CqulIID-VUq6UAwjVezB8RS8130_provenance.
- NP926871.RAUUgiraPADDZZ_gzj889CqulIID-VUq6UAwjVezB8RS8130_assertion SIO_000772 21952943 NP926871.RAUUgiraPADDZZ_gzj889CqulIID-VUq6UAwjVezB8RS8130_provenance.
- NP926871.RAUUgiraPADDZZ_gzj889CqulIID-VUq6UAwjVezB8RS8130_assertion wasDerivedFrom befree-2016 NP926871.RAUUgiraPADDZZ_gzj889CqulIID-VUq6UAwjVezB8RS8130_provenance.
- NP926871.RAUUgiraPADDZZ_gzj889CqulIID-VUq6UAwjVezB8RS8130_assertion wasGeneratedBy ECO_0000203 NP926871.RAUUgiraPADDZZ_gzj889CqulIID-VUq6UAwjVezB8RS8130_provenance.